Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Adverse drug events

NSAID use may prevent fertile women from ovulating

Small study shows anti-inflammatory drugs temporarily prevented ovulation in 75% of subjects.

Study warns that women who hope to become pregnant should steer clear of non-steroidal anti-inflammatory pain killers (NSAIDs), because they prevent ovulation in as many as 75% of fertile women. In the image, a woman holds up a negative pregnancy test

Source: Shutterstock.com

Non-steroidal anti-inflammatory pain killers inhibit ovulation so should be avoided by women wanting to become pregnant, a rheumatologist has warned

A doctor has warned that women who hope to become pregnant should steer clear of non-steroidal anti-inflammatory pain killers (NSAIDs), because they could prevent ovulation in as many as 75% of fertile women, according to a small study he conducted.

Previous research has suggested that NSAIDs can stop eggs produced by the ovary from being released — termed “luteinised unruptured follicles”. To further investigate, Sami Salman, a rheumatologist at the University of Baghdad, Iraq, recruited fertile women with minor ailments like mild back pain to take part in a study, the results of which were presented at the Annual European Congress of Rheumatology[1] in Rome on 11 June 2015.

Of the 49 women who took part in the trial, 16 were given diclofenac, 12 naproxen, 11 etoricoxib and 10 placebo. The drugs were started on the tenth day of the women’s menstrual cycle, the point at which the ovary is preparing to release an egg. An ultrasound of the ovaries was performed along with a blood test to measure hormone levels.

The drugs were taken at the recommended dose for the next ten days, at which point the tests were repeated. In the placebo group, all of the women ovulated. But ovulation only occurred in 6.3% of the diclofenac group, 25% of the naproxen group and 27.3% of the etoricoxib group.

Describing this is a “shocking finding”, Salman said he was not expecting the effect to be so dramatic. He explained that he wanted to highlight the research because “so many” women have trouble conceiving. But, despite NSAIDs having been identified as inhibiting ovulation, “no one is asking women if they’re taking these drugs or discussing whether they should stop taking them”, said Salman.

As well as inhibiting ovulation, progesterone levels were lower in the women who took NSAIDs, which Salman said could prevent implantation of a fertilised egg if a woman were to ovulate. “It would be unlikely to be healthy and probably lead to an early miscarriage,” he added.

To evaluate the duration of the effect of NSAIDs on ovulation, tests were repeated during the women’s next menstrual cycle and they were all found to have ovulated. “It is reassuring to know that the observed effect seems to be reversible,” said Salman.

Salman conceded that the study was very small and called for larger, more comprehensive, studies, but recommended that women hoping to become pregnant do not take NSAIDs.

Ibuprofen, one of the most commonly taken over-the-counter NSAID medications, was not included in the study. “Without evidence, I cannot predict if it has the same effect as other NSAIDs on ovulation,” said Salman, adding that NSAIDs taken at other points during the menstrual cycle are unlikely to prevent ovulation.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068779

Readers' comments (1)

  • Fascinating! If this is a class effect it begs the question what role ibuprofen as a GSL is having on the fertility of Western populations - particularly if women are using it for period pain!

    JWalker

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Workplace Drug Testing

    Workplace Drug Testing

    Explains drug testing regulatory frameworks and all aspects of drug analysis. Case studies of successful programmes are included.

    £79.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £42.00Buy now
  • Remington Education: Pharmaceutics

    Remington Education: Pharmaceutics

    Case studies and MCQs explaining the pharmaceutics behind drug delivery.

    £32.00Buy now
  • FASTtrack: Pharmacology

    FASTtrack: Pharmacology

    FASTtrack: Pharmacology is a study guide providing an account of drug action, as well as dealing with molecular pharmacology at a more advanced level.

    £24.00Buy now
  • Dale and Appelbe's Pharmacy and Medicines Law

    Dale and Appelbe's Pharmacy and Medicines Law

    This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.

    £55.00Buy now
  • Pharmacy Case Studies

    Pharmacy Case Studies

    Understand the application of therapeutics in clinical practice with Pharmacy Case Studies. This book helps you to demonstrate the knowledge gained during your studies.

    £32.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.